Subscribe Now Advertise

Categories

search Result

Trump 2.0 may boost Indian pharma opportunities

Experts highlight that higher tariffs on Chinese goods might enable Indian firms to fill supply gaps in the US generic drug market, a critical region that accounts for 30% of Indian pharma sales and 40% of global volume share.Read more

AptarGroup breaks ground on new pharma plant in Taloja, near Mumbai

Spanning 4,400 square metres, the new plant will be constructed adjacent to Aptar's existing Mumbai facility, which opened in 2023. Read more

Role of AI and automation in quality control in the pharmaceutical industry

In recent months, the Indian pharma industry, accounting for 20% of the global generic exports, has been facing problems related to quality from global & local regulators. By leveraging AI and automation, the industry can not only overcome quality challenges, but can also help it reach the target of $ 130 billion by 2030, says Sanskriti Ramachandran.Read more

AI simulates trials to predict outcomes and reduce costly methods: Mudit Agarwal

In conversation with Sanskriti Ramachandran, Mudit Agarwal, Founder and CEO, Agrim Tech Services, explains the use of AI in pharma and gives his insights on the pharma industry.Read more

Indian pharma sector poised for 8-10% growth this fiscal: CRISIL

Following a successful year with approximately 10% growth, the outlook is bolstered by easing pricing pressures in the US generics market and improved operating leverage, which is expected to raise operating margins by 70-80 basis points to around 22.5%. Read more

Nearly 2,000 drug manufacturing plants overdue for FDA inspections post-COVID

These overdue inspections affect about 42% of the 4,700 registered drug manufacturing plants that were reviewed by the FDA before May 2019.Read more

Indian pharma exports surge with 8.36% growth in July 2024

The Indian pharmaceutical industry is projected to grow to $65 billion by 2024 and to $130 billion by 2030. Read more

DCGI introduces guidelines for product traceability in pharma supply chain

The introduction of these guidelines is particularly timely, as the Indian pharmaceutical industry has come under scrutiny following reports linking spurious cough syrups from India to children's deaths in Gambia, Cameroon, and Uzbekistan.Read more

CDSCO mandates GMP compliance for sterile equipment manufacturers

This move marks a significant shift, as GMP compliance was previously required only for drug manufacturers.Read more

India’s API industry expected to grow 7-8% in FY25

The operating profit margin (OPM) is forecasted to rise to 12-14%, up from 11-13% in the previous fiscal year.Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016